GlassScriptPhysician profile
Lisa Michelle Morris
NPI 1881839041
$4,057.60
in general payments reported to CMS, 2019-2025
14 companies · $2,930 in 2025
The $2,930 reported for 2025 was more than what 88% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $93.48 · 2021: $334 · 2022: $278 · 2023: $105 · 2024: $317 · 2025: $2,930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,500 · Food and Beverage: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,500.00 |
| Food and Beverage | $852.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $3,019.08 | 2020-2025 | |
| Medtronic, INC. | $473.04 | 2024-2025 | Stealthstation S8 Platform, Pteye Parathyroid Detection System |
| Regeneron Healthcare Solutions, INC. | $220.55 | 2021 | |
| Glaxosmithkline, LLC. | $100.00 | 2022 | |
| Incyte Corporation | $36.13 | 2021-2022 | |
| Stryker Corporation | $34.03 | 2023 | Na |
| Baxter Healthcare | $32.53 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Astrazeneca Pharmaceuticals LP | $32.04 | 2022-2023 | |
| Grifols USA, LLC | $23.44 | 2022 | |
| Csl Behring | $19.59 | 2023 | Hizentra |
| Genzyme Corporation | $18.41 | 2024 | |
| Alk-Abello, INC | $17.74 | 2022 | |
| Kaleo, INC. | $17.68 | 2021 | |
| Sobi, INC | $13.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.